Research has shown that art can help reduce stress, anxiety, and promote healing. With this in mind, Dana-Farber has built a collection of works by local and international artists, which are on display in public spaces and patient areas throughout the Yawkey Center for Cancer Care. Among the works are Andy Warhol's Souper Dress, a Roy Lichtenstein print, Julian Opie LCD works, Harry Benson's photos of the Beatles, and a blown-glass piece by Dale Chihuly. Most of the works are donations. Joyce Kulhawik talks to cancer patients and staff who helped create the collection and the new audio tour. Learn more: http://www.dana-farber.org/AudioArtTour
Every year in the US, more than 70,000 young adults are diagnosed with cancer. Many young adult patients find coping with cancer particularly challenging because of the way it disrupts their lives, changes relationships and affects college or career.
After four years of treatment for acute lymphoblastic leukemia, including a stem cell transplant, young Charlie is happy and healthy. Here, his parents and brothers reflect on how Charlie's cancer treatment affected the family. Read the rest of Charlie's story: http://www.dana-farber.org/CharliesStory
When Charlie began receiving care for acute lymphoblastic leukemia at Dana-Farber/Children's Hospital Cancer Center at age 4, his mother, Caroline, sent email updates to her family and friends. After a brief remission, Charlie's cancer came back, and he returned for more treatment, including a stem cell transplant. Caroline's reflections grew into a touching chronicle of four years in the life of a child with cancer.
Published on Jun 27, 2013
I was diagnosed with a stage four ovarian germ cell tumor on June 11, 2012. I went through surgery and four cycles of BEP chemotherapy and have been in remission as of September 2012.
This is an overview of my story. It is basically an introduction to my blog:
This is my story. I am also trying to help others in similar situations.
A pilot phase 2 clinical trial is testing the feasibility of the targeted drug palbociclib combined with endocrine therapy as adjuvant therapy for stage II and III breast cancer. The research was reported at the annual meeting of the American Society of Clinical Oncology (ASCO).